A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Journal article published in 2018 by
Marta Castroviejo‐Bermejo,
Cristina Cruz,
Alba Llop‐Guevara,
Sara Gutiérrez‐Enríquez,
Mandy Ducy,
Yasir Hussein Ibrahim,
Albert Gris‐Oliver 
,
Benedetta Pellegrino,
Alejandra Bruna,
Marta Guzmán,
Olga Rodríguez,
Judit Grueso,
Sandra Bonache,
Alejandro Moles‐Fernández,
Guillermo Villacampa
and other authors.
,
Benedetta Pellegrino,
Alejandra Bruna,
Marta Guzmán,
Olga Rodríguez,
Judit Grueso,
Sandra Bonache,
Alejandro Moles‐Fernández,
Guillermo Villacampa
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 